Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00887159Phase 2Completed
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
PrincipalinvestigatorStart date: 2009-07-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

ECOG-ACRIN Cancer Research Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yanyan Lou, M.D., Ph.D.

Mayo Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Alberto Chiappori

Moffitt Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Taofeek Owonikoko, MD, PhD

Emory University

Related
1 trials

Shared therapeutic areas:

Recurrent Small Cell Lung Carcinoma
Similarity Score15%

Ravi Salgia, MD

City of Hope Medical Center

Related
4 trials

Shared therapeutic areas:

Extensive Stage Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Manali Patel

Stanford University

Related
1 trials

Shared therapeutic areas:

Extensive Stage Small Cell Lung Carcinoma
Similarity Score15%

Albert Attia, MD

Vanderbilt-Ingram Cancer Center

Related
2 trials

Shared therapeutic areas:

Extensive Stage Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Hongbin Chen, MD

Roswell Park Cancer Institute

Related
1 trials

Shared therapeutic areas:

Recurrent Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Dwight Owen, MD, MS

Ohio State University Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Small Cell Lung Carcinoma
Similarity Score15%

Apar Ganti, MD

University of Nebraska

Related
3 trials

Shared therapeutic areas:

Recurrent Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

James Welsh

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Extensive Stage Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00887159Phase 2PrincipalInvestigator

A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
Completed

All 1 trials loaded